Author： Leone Roberti Maggiore Umberto Valenzano Menada Mario Venturini Pier Luigi Ferrero Simone
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.8, 2013-08, pp. : 1049-1062
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Sorafenib: In Advanced Renal Cancer
By McKeage Kate Wagstaff Antona J.
Drugs, Vol. 67, Iss. 3, 2007-01 ,pp. :
Access to resources
Recommend
Sorafenib for the treatment of renal cancer
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. :
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 7, 2012-05 ,pp. :
Sorafenib enhances HRQOL in renal cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 533, 2007-01 ,pp. :
Sorafenib on TARGET in advanced renal cancer
Inpharma, Vol. 1, Iss. 1597, 2007-01 ,pp. :